Ticker Details
Amicus Therapeutics, Inc. Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines.
IPO Date:	May 31, 2007
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.49B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.23 | 2.63%
Avg Daily Range (30 D):	$0.02 | 0.12%
Avg Daily Range (90 D):	$0.09 | 0.99%

Institutional Daily Volume
Avg Daily Volume:	1.66M
Avg Daily Volume (30 D):	8.41M
Avg Daily Volume (90 D):	8.04M

Trade Size
Avg Trade Size (Sh.):	155
Avg Trade Size (Sh.) (30 D):	458
Avg Trade Size (Sh.) (90 D):	286

Institutional Trades
Total Institutional Trades:	8,379
Avg Institutional Trade:	$2.96M
Avg Institutional Trade (30 D):	$3.83M
Avg Institutional Trade (90 D):	$3.42M
Avg Institutional Trade Volume:	.26M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$3.77M
Avg Closing Trade (30 D):	$7.21M
Avg Closing Trade (90 D):	$8.28M
Avg Closing Volume:	341.05K

News

Jan 7, 2026 @ 7:27 PM Halper Sadeh LLC Encourages EKSO, FOLD, CWAN, JHG ... Source: Halper Sadeh Llc

Jan 6, 2026 @ 7:58 PM Halper Sadeh LLC Encourages EKSO, FOLD, CWAN, JHG ... Source: Halper Sadeh Llc

Dec 23, 2025 @ 8:19 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith

Dec 23, 2025 @ 6:05 PM What's Going On With BioMarin Stock On Tuesday? Source: Vandana Singh

Dec 20, 2025 @ 4:26 PM Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB... Source: Halper Sadeh Llc

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$.06	$-.08
Diluted EPS		$.06	$-.08
Revenue		$169.06M	$154.69M
Gross Profit		$149.59M	$139.47M
Net Income / Loss		$17.31M	$-24.42M
Operating Income / Loss		$34.27M	$-9.47M
Cost of Revenue		$19.47M	$15.22M
Net Cash Flow		$31.84M	$-22.72M
PE Ratio